These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 23959714)

  • 1. Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing-remitting multiple sclerosis.
    Hradilek P; Zeman D; Tudik I; Zapletalova O; Ulmann V
    Mult Scler; 2014 Apr; 20(5):639-40. PubMed ID: 23959714
    [No Abstract]   [Full Text] [Related]  

  • 2. Disseminated infection with cutaneous involvement caused by Mycobacterium malmoense in an immunocompromised patient.
    Pigem R; Cairó M; Martínez-Lacasa X; Irigoyen D; Miró JM; Acevedo J; Fernández J; Alsina-Gibert M
    J Am Acad Dermatol; 2013 Oct; 69(4):e192-3. PubMed ID: 24034397
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrence of active tuberculosis following resumption of anti-TNF-α therapy in a patient with Crohn's disease.
    Masiá M; Martínez M; García-Sepulcre MF; Sáez J; Gutiérrez F
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):249-50. PubMed ID: 24429322
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe cutaneous hand infection: Mycobacterium marinum in an immunosuppressed patient.
    Argyropoulou OD; Zampeli E; Sipsas NV; Tzioufas AG; Moutsopoulos HM
    Clin Exp Rheumatol; 2018; 36(6):1117. PubMed ID: 30148427
    [No Abstract]   [Full Text] [Related]  

  • 5. Daclizumab (Zinbryta) for multiple sclerosis.
    Med Lett Drugs Ther; 2016 Sep; 58(1503):117-9. PubMed ID: 27603962
    [No Abstract]   [Full Text] [Related]  

  • 6. [Swelling of right knee in an immunologically compromised patient].
    Cajigas-Pezo D; Lorenzo-Hernandez A; Vives-Rivero GR; Rentero-Martínez Z
    Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):481-2. PubMed ID: 22521279
    [No Abstract]   [Full Text] [Related]  

  • 7. Olecranon bursitis secondary to Mycobacterium kansasii infection in a patient receiving infliximab for Behcet's disease.
    Malkin J; Shrimpton A; Wiselka M; Barer MR; Duddridge M; Perera N
    J Med Microbiol; 2009 Mar; 58(Pt 3):371-373. PubMed ID: 19208889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium kansasii septicaemia in an AIDS patient complicated by acute respiratory distress syndrome and acute liver failure.
    Shaaban H; Layne T; Sensakovic JW; Boghossian J
    Int J STD AIDS; 2014 Feb; 25(2):152-4. PubMed ID: 23970643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidly growing non-tuberculous mycobacterial infection in a renal transplant patient after alemtuzumab induction.
    Hazara AM; Edey M; Roy A; Bhandari S
    Transpl Infect Dis; 2014 Oct; 16(5):847-52. PubMed ID: 25040696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract].
    Andréjak C; Lescure FX; Schmit JL; Jounieaux V
    Rev Mal Respir; 2011 Dec; 28(10):1293-309. PubMed ID: 22152937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breathlessness, night sweats, and weight loss on natalizumab.
    Dahdaleh D; Altmann DM; Malik O; Nicholas RS
    Lancet; 2012 Aug; 380(9843):726-7. PubMed ID: 22920745
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycobacterium kansasii Infection in a Patient Receiving Biologic Therapy-Not All Reactive Interferon Gamma Release Assays Are Tuberculosis.
    Saleem N; Saba R; Maddika S; Weinstein M
    Am J Med Sci; 2017 Apr; 353(4):394-397. PubMed ID: 28317629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium kansasii endobronchial ulcer in a nonimmunocompromised patient.
    Manali ED; Tomford WJ; Liao DW; Farver C; Mehta AC
    Respiration; 2005; 72(3):305-8. PubMed ID: 15942302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated Mycobacterium chelonae Infection Identified by Repeated Skin Sampling and Molecular Methods in a Patient with Rheumatoid Arthritis.
    Tsutsumi R; Yamada N; Yoshida Y; Nakanaga K; Ishii N; Yamamoto O
    Acta Derm Venereol; 2016 Jan; 96(1):132-3. PubMed ID: 26122695
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathogenicity of Mycobacterium kansasii].
    Vesenbeckh S; Wagner S; Mauch H; Roth A; Streubel A; Rüssmann H; Bauer TT; Matthiessen W; Schönfeld N
    Pneumologie; 2014 Aug; 68(8):526-31. PubMed ID: 25046682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cavitary pulmonary disease in a patient treated with natalizumab.
    de Masson A; Maillart E; Veziris N; Meyssonnier V; Papeix C; Caumes E
    Presse Med; 2014 Sep; 43(9):1009-12. PubMed ID: 24742610
    [No Abstract]   [Full Text] [Related]  

  • 17. Tenosynovitis of the Hands Caused by Mycobacterium kansasii in a patient with scleroderma.
    Gerster JC; Duvoisin B; Dudler J; Berner IC
    J Rheumatol; 2004 Dec; 31(12):2523-5. PubMed ID: 15570663
    [No Abstract]   [Full Text] [Related]  

  • 18. Skin and Soft Tissue Infections Caused by Mycobacterium chelonae: More Common Than Expected?
    Uslu U; Böhm O; Heppt F; Sticherling M
    Acta Derm Venereol; 2019 Sep; 99(10):889-893. PubMed ID: 31141157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [2012: Update on diagnosis and treatment of multiple sclerosis].
    Havla J; Kümpfel T; Hohlfeld R
    Dtsch Med Wochenschr; 2012 Apr; 137(17):894-9. PubMed ID: 22492476
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary Mycobacteriosis in a Patient Receiving Chronic Methotrexate Treatment.
    Dal Molín-Veglia MA; Sánchez-Martínez F; Fernández-Alarza AF; Domínguez-Álvarez M
    Arch Bronconeumol (Engl Ed); 2018 Apr; 54(4):225-226. PubMed ID: 29108758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.